Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Levobupivacaine for Pain Relief After Esophageal ESD
2024-510912-66-00Phase 4Authorised
- Sponsor
- St. Antonius Ziekenhuis
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of levobupivacaine in esophageal cancer, esophageal dysplasia and None (2 arms), sponsored by St. Antonius Ziekenhuis. Planned start Aug 2024; status: authorised.
02
Drugs
levobupivacaine
03
Conditions
esophageal canceresophageal dysplasia
Beyond the preview
Go deeper on 2024-510912-66-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-510912-66-00.